Furthermore, the gene expression signature of our cancer organoids confirmed the findings found in the PTC samples, which also showed enrichment of genes associated to p53, focal adhesion, ECM-receptor interactions, EMT and inflammatory pathways [73–75]. The gene discussed is TP53; the disease is cancer.